Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®
Public ClinicalTrials.gov record NCT00319553. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Comparison in US Adolescents of the Safety and Immunogenicity of Two Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccines: ADACEL™ and BOOSTRIX®
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a descriptive study to evaluate the safety and immunogenicity of ADACEL® and BOOSTRIX® vaccines among US adolescents.
Study identification
- NCT ID
- NCT00319553
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 647 participants
Conditions and interventions
Conditions
Interventions
- ADACEL®:Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed Biological
- BOOSTRIX®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed Biological
Biological
Eligibility (public fields only)
- Age range
- 11 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2006 (Type not available)
- Primary completion
- Oct 2008 (Actual)
- Completion
- Dec 2008 (Actual)
- Last update posted
- Oct 5, 2012
2006 – 2008
United States locations
- U.S. sites
- 10
- U.S. states
- 4
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Annapolis | Maryland | 21401 | — |
| Not listed | Baltimore | Maryland | 21201 | — |
| Not listed | Frederick | Maryland | 21702 | — |
| Not listed | Durham | North Carolina | 27704 | — |
| Not listed | Durham | North Carolina | 27705 | — |
| Not listed | Franklin | Tennessee | 37067 | — |
| Not listed | Bellevue | Washington | 98005 | — |
| Not listed | Mercer Island | Washington | 98040-2758 | — |
| Not listed | Sammamish | Washington | 98075 | — |
| Not listed | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00319553, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 5, 2012 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00319553 live on ClinicalTrials.gov.